SE8800981D0 - A recombinant fusion protein, its use and a recombinant vector - Google Patents

A recombinant fusion protein, its use and a recombinant vector

Info

Publication number
SE8800981D0
SE8800981D0 SE8800981A SE8800981A SE8800981D0 SE 8800981 D0 SE8800981 D0 SE 8800981D0 SE 8800981 A SE8800981 A SE 8800981A SE 8800981 A SE8800981 A SE 8800981A SE 8800981 D0 SE8800981 D0 SE 8800981D0
Authority
SE
Sweden
Prior art keywords
recombinant
fusion protein
recombinant vector
vector
recombinant fusion
Prior art date
Application number
SE8800981A
Other languages
English (en)
Other versions
SE8800981A (sv
Inventor
Per-Ake Nygren
Lars Abrahamsen
Mathias Uhlen
Original Assignee
Nygren Per Ake
Lars Abrahamsen
Mathias Uhlen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nygren Per Ake, Lars Abrahamsen, Mathias Uhlen filed Critical Nygren Per Ake
Priority to SE8800981A priority Critical patent/SE8800981A/sv
Publication of SE8800981D0 publication Critical patent/SE8800981D0/sv
Publication of SE8800981A publication Critical patent/SE8800981A/sv
Priority to JP6234689A priority patent/JPH0242990A/ja
Priority to EP89850091A priority patent/EP0333691A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE8800981A 1988-03-17 1988-03-17 A recombinant fusion protein, its use and a recombinant vector SE8800981A (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE8800981A SE8800981A (sv) 1988-03-17 1988-03-17 A recombinant fusion protein, its use and a recombinant vector
JP6234689A JPH0242990A (ja) 1988-03-17 1989-03-16 組換え融合タンパク質および組換えベクター
EP89850091A EP0333691A3 (en) 1988-03-17 1989-03-16 A recombinant fusion protein, its use and a recombinant vector

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8800981A SE8800981A (sv) 1988-03-17 1988-03-17 A recombinant fusion protein, its use and a recombinant vector

Publications (2)

Publication Number Publication Date
SE8800981D0 true SE8800981D0 (sv) 1988-03-17
SE8800981A SE8800981A (sv) 1988-10-14

Family

ID=20371731

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8800981A SE8800981A (sv) 1988-03-17 1988-03-17 A recombinant fusion protein, its use and a recombinant vector

Country Status (3)

Country Link
EP (1) EP0333691A3 (sv)
JP (1) JPH0242990A (sv)
SE (1) SE8800981A (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595887A (en) * 1990-07-16 1997-01-21 Bionebraska, Inc. Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment
JPH04126092A (ja) * 1990-09-14 1992-04-27 Nippon Kayaku Co Ltd 大腸菌由来蛋白の除去方法
AU4415796A (en) * 1994-12-07 1996-06-26 Bionebraska, Inc. Production of c-terminal amidated peptides from recombinant protein constructs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
DE3410437A1 (de) * 1984-03-22 1985-09-26 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von proteinen
SE8505922D0 (sv) * 1985-12-13 1985-12-13 Kabigen Ab Construction of an igg binding protein to facilitate downstream processing using protein engineering
US4828988A (en) * 1986-05-15 1989-05-09 Smith Kline - Rit Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine

Also Published As

Publication number Publication date
JPH0242990A (ja) 1990-02-13
SE8800981A (sv) 1988-10-14
EP0333691A2 (en) 1989-09-20
EP0333691A3 (en) 1990-08-08

Similar Documents

Publication Publication Date Title
DK0397633T3 (da) Fibronectinbindende protein samt fremstilling deraf
DE69131580T2 (de) GDF-1 und UOG1 Proteine
AU2964489A (en) Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
AU573523B2 (en) Functional human urokinase proteins
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
DK295188D0 (da) Fibronectinbindende protein og fremgangsmaade til fremstilling heraf
AU4401689A (en) Recombinant dna coding for bacillus thuringiensis endotoxin
FI841288A0 (fi) Rekombinant-dna-kod foer uttryckning av polypeptid.
DE69125381D1 (de) Proteinstruktur des pflanzlichen toxins gelonin
NO922421L (no) Collagenbindende protein, samt fremstilling derav
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
SE8800981A (sv) A recombinant fusion protein, its use and a recombinant vector
GR3006045T3 (sv)
DE68918519T2 (de) DNA, welche für ein antikoagulierendes Polypeptid kodiert.
SE8802176D0 (sv) Fusion protein and its use
JPS6485093A (en) Protein arp having activity of binding immunoglobulin a, method for cloning and manifesting said protein, corresponding bector and host, reagent kit and drug composition
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein
ES2059823T3 (es) Metodos y sistemas para producir antigenos de hiv.
IE882662L (en) Dna sequences, recombinant dna molecules for producing¹soluble t4 proteins

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8800981-6

Effective date: 19890629